INTERVIEW: Carmat stays on the beat with potential 2016 artificial heart CE mark
This article was originally published in Clinica
Carmat has taken another step towards approval of its biocompatible artificial heart after developing a portable console that has allowed one patient implanted with the system to return home.
You may also be interested in...
After years of setbacks, the company will launch its device in Europe as a bridge to transplant in heart failure patents.
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.